Fructose-1,6-diphosphate in the treatment of oleander toxicity in dogs

Veterinary and Human Toxicology

Volumn 41, Issue 1, 1999, Pages 9-15

  Markov, Angel K ^a   Payment, Michael F ^a   Hume, Arthur S ^a   Rajeswara Rao, M ^b   Markov, Muriel A ^c   Skelton, Thomas N ^a   Lehan, Patrick H ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b SRI VENKATESWARA UNIVERSITY   (India)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC GLYCOSIDE; DIGITOXIGENIN; DIGITOXIN; FRUCTOSE 1,6 BISPHOSPHATE; NERIUM OLEANDER EXTRACT; OLEANDRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOTOXICITY; CONTROLLED STUDY; DOG; DOSE RESPONSE; GASTROINTESTINAL TOXICITY; HEART VENTRICLE ARRHYTHMIA; HYPERKALEMIA; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OLEANDER;

ANIMALIA; CANIS FAMILIARIS; MAGNOLIOPHYTA; NERIUM; NERIUM OLEANDER;

EID: 0032911107     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Osterloh J, Herold S, Pond S: Oleander interference in the digoxin radioimmunoassay in a fatal ingestion. JAMA 247: 596-1597, 1982.
2. Haynes BE, Bessen HA, Wightman WD: Oleander tea: Herbal draught with death. Ann Emerg Med 14: 350-353, 1985.
3. Blum LM, Rieders F: Oleandrin distribution in a fatality from rectal and oral Nerium oleander extract administration. J Analyt Toxicol 11: 219-221, 1987.
4. Saravanapavananthan N, Ganeshamoorthy J: Yellow oleander poisoning - A study of 170 cases. Forensic Sci Int 36: 247-250, 1988.
5. Clark RF, Selden BS, Curry SC: Digoxin-specific Fab fragments in the treatment of oleander toxicity in canine model. Ann Emerg Med 20: 1073-1077, 1991.
6. Shumaik GM, Wu AW, Ping AC: Oleander poisoning: Treatment with digoxin-specific Fab antibody fragments. Ann Emerg Med 17: 732-735, 1988.
7. Markov AK, Oglethorpe NC, Blake TM et al: Hemodynamic, electrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia. Am Heart J 100: 639-646, 1980.
8. Marchionni N, Conti A, De Alfieri W et al: Hemodynamic and electrocardiographic effects of fructose-1,6-diphosphate in acute myocardial infarction. Am J Cardiol 56: 266-269, 1985.
9. Markov AK, Oglethorpe N, Blake TM et al: Attenuation of digitalis toxicity with fructose-1,6-diphosphate. Clin Res 31: 866A, 1983.
10. Markov A, Oglethorpe N, Lehan P: Prevention of arrhythmias with fructose diphosphate in acute myocardial ischemia. European Heart J 12: 218A, 1991.
11. Cattani L, Costrini R, Cerilli C et al: Fructose-1,6-diphosphate dependence of the toxicity and uptake of potassium ions. Agressologie 21: 263-264, 1980.
12. Jones LR, Besch HR Jr, Fleming JW et al: Separation of vesicles of cardiac sarcolemma fron vesicles of cardiac sarcoplasmic reticulum. J Biol Chem 254: 530-539, 1979.
13. Baginski ES, Foa PP, Zak B: Determination of phosphate: Study of labile organic phosphate interference. Clin Chem Acta 15: 155-158, 1967.
14. + ATPase and p-nitrophenyl phosphatase. J Biol Chem 253: 3487-3493, 1978.
15. Cherbakoff A, Toyama S, Hamilton WF: Relation between coronary sinus plasma potassium and cardiac arrhythmia. Circ Res 5: 517-521, 1957.
16. Regan TJ, London BL, Binak K et al: Sympathomimetics as antagonists of strophanthidin's ionic and arrhythmic effect. Circ Res 11: 17-25, 1962.
17. Zhan JN, Zhang FM, Ma WS et al: Protective effect of exogenous fructose-1,6-diphosphate in cardiogenic shock. Cardiovasc Res 22: 927-932, 1988.
18. Markov AK, Oglethorpe N, Young DB et al: Irreversible hemorrhagic shock - Treatment and cardiac pathophysiology. Circ Shock 8: 9-19, 1981.
19. Markov AK, Turner MD, Oglethorpe N et al: Fructose 1-6 diphosphate: An agent for treatment of experimental endotoxin shock. Surgery 90: 482-488, 1981.
20. Markov AK, Terry J, White TZ et al: Increasing survival of dogs subjected to hemorrhagic shock by administration of fructose 1-6 diphosphate. Surgery 102: 515-527, 1987.
21. Engel FL: Metabolic aspects of shock problem. J Mt Sinai Hosp 12: 152-169, 1945.
22. Zinovev IUV: Increase in the rate of anerobic glycolysis as an index of hypoxia in hemorrhagic shock. Vop Med Khim 23: 151-155, 1977.
23. Kubler W, Spieckermann PG: Regulation of glycolysis in the ischemic and the anoxic myocardium. J Mol Cell Cardiol 1: 351-377, 1970.
24. Passonneau JV, Lowry OH: Phosphofructokinase and the Pasteur effect. Biochem Biophys Res Commun 7: 10-15, 1962.
25. Williamson JR: Metabolic control in the perfused rat heart. In Chance B, Estabrook RW, Williamson HR eds: Control in Energy Metabolism. Academic Press, New York: 333-346, 1965.
26. Opie LH, Owen P: Glycolysis in acute experimental myocardial infarction: Pathways of metabolism and preliminary results. In Bayusz E, Rona G eds: Recent Advances in Studies on Cardiac Structure and Metabolism, Vol 2. University Park Press, Baltimore: 567-579, 1973.
27. Kirtley ME, McKay M: Fructose-1,6-diphosphate, a regulator of metabolism. Molec Cell Biochem 18: 141-149, 1977.
28. Hood K, Holloway R: The significant role of fructose-1,6-diphosphate in regulatory kinetics of phosphofructokinase. FEBS Letter 68: 8-14, 1976.
29. Iurovitskii IUG, Milman LS: Regulation of pyruvate kinase activity by frustose-1,6-diphosphate in the developing embryo. Dokl Akad Nauk SSSR 175: 1404-1406, 1967.
30. Debar J, Debar TR, Omachi A: Influence of digoxin on labile and inorganic phosphate lactate glycogen, potassium and sodium in dog ventricle. Circ Res 5: 504-509, 1957.
31. Rigobello MP, Bianchi M, Deana R et al: Interaction of fructose 1,6-diphosphate with some cell membranes. Agressologie 23: 63-66, 1982.
32. Tavazzi B, Starnes JW, Lazzarino G et al: Exogenous fructose-1,6-biphosphate is a metabolizable substrate for the isolated normoxic rat heart. Basic Res Cardiol 87: 280-289, 1992.
33. Hardin CD, Roberts TM: Metabolism of exogenously applied fructose 1,6-biphosphate in hypoxic vascular smooth muscle. Am J Physiol 267: H2325-H2332, 1994.